Effects of a Virtual Reality Intervention on Mental Health Outcomes and Academic Success in Physical Therapy Students
Launched by BELMONT UNIVERSITY · Aug 20, 2024
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
This study is exploring the impact of an 8-week virtual reality intervention among graduate physical therapy students. Self-report measures of anxiety, depression and stress will be collected pre/post to assess the impact of the virtual reality intervention.
Purpose:
1. Determine if there is an impact of a virtual reality intervention on symptoms of anxiety, depression and stress levels in first year physical therapy doctoral students
2. Explore correlations between performance, anxiety, depression, stress and First Resort use in first year physical therapy doctoral students
3. Explore th...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Physical Therapy students enrolled at a single university in the southern United States during the fall 2024 semester
- • -
- Exclusion Criteria:
- • Patient Health Questionnaire-8 score of 15 or more General Anxiety Disorder-7 score of 15 or more History of seizures History of motion sickness History of epilepsy History of balance impairment History of significant visual History of auditory impairment
- • -
About Belmont University
Belmont University is a leading academic institution dedicated to advancing healthcare through innovative research and education. As a clinical trial sponsor, Belmont University focuses on fostering collaboration between researchers, healthcare professionals, and community partners to conduct rigorous clinical studies that address critical health challenges. With a commitment to ethical standards and patient safety, Belmont University aims to contribute to the development of effective interventions and therapies, enhancing the quality of care and improving health outcomes within diverse populations.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Nashville, Tennessee, United States
Patients applied
Trial Officials
Sue E Curfman, PT, DHSc
Principal Investigator
Belmont University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported